Arcus Biosciences, Inc. <RCUS.N>: Wells Fargo raises target price to $26 from $23
RCUS•Related News
Fox posts fiscal 2026 Q4, full-year earnings release report link
FOXA•
CION Investment Q2 net asset value per share rises 3.5%
CION•
Helix returns to profit in Q2 FY26 with net income of $22.7 million; revenue rises 21% to $304 million vs Q2 FY25
HLX•
Theriva Biologics doses first patient in VIRAGE2 Phase 2a trial of VCN-01 for metastatic pancreatic cancer
TOVX•
Shift4 slides after cutting annual revenue forecast
FOUR•